Editorial comment on: Safety and tolerability of adjuvant topical tacrolimus treatment in boys with lichen sclerosus: a prospective phase 2 study.
Barbagli
Guido
G
Lazzeri
Massimo
M
D000287:Administration, Topical; D017024:Chemotherapy, Adjuvant; D002648:Child; D017322:Clinical Trials, Phase II as Topic; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects; D018459:Lichen Sclerosus et Atrophicus / Q000188:drug therapy / Q000601:surgery; D008297:Male; D011446:Prospective Studies; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects
D007166:Immunosuppressive Agents; D016559:Tacrolimus